XBI icon

SPDR S&P Biotech ETF

763 hedge funds and large institutions have $10.2B invested in SPDR S&P Biotech ETF in 2024 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 238 increasing their positions, 269 reducing their positions, and 73 closing their positions.

Holders
763
Holders Change
+8
Holders Change %
+1.06%
% of All Funds
11.04%
Holding in Top 10
21
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+16.67%
% of All Funds
0.3%
New
88
Increased
238
Reduced
269
Closed
73
Calls
$2.8B
Puts
$3.33B
Net Calls
-$526M
Net Calls Change
+$836M
Name Market Value Shares Shares
Change
Shares
Change %
SA
826
Scarborough Advisors
Maryland
-357 Closed
IF
827
Integrity Financial
Wyoming
-261 Closed
WSCM
828
Wellington Shields Capital Management
New York
-200 Closed
DFA
829
DHJJ Financial Advisors
Illinois
-155 Closed
Deutsche Bank
830
Deutsche Bank
Germany
-113 Closed
OWA
831
Opal Wealth Advisors
New York
-100 Closed
AFWM
832
Abich Financial Wealth Management
Virginia
-38 Closed
DIP
833
DT Investment Partners
Pennsylvania
-32 Closed
BGAI
834
Bruce G. Allen Investments
Colorado
-30 Closed
ACA
835
American Capital Advisory
Idaho
-29 Closed
OLVIG
836
Oliver Lagore Vanvalin Investment Group
Michigan
-25 Closed
RWMG
837
Redwood Wealth Management Group
New Jersey
-20 Closed
FIA
838
FNY Investment Advisers
New York
-10 Closed
HT
839
HAP Trading
New York
SCM
840
Soleus Capital Management
Connecticut
IC
841
Ikarian Capital
Texas
PCM
842
Pentwater Capital Management
Florida
ECM
843
ExodusPoint Capital Management
New York
Squarepoint
844
Squarepoint
New York
SI
845
Sofinnova Investments
California
PP
846
Paloma Partners
Connecticut
TC
847
Torno Capital
Massachusetts
ORAM
848
One River Asset Management
Connecticut
SAMU
849
SONA Asset Management (US)
New York
RA
850
Rosalind Advisors
Ontario, Canada